These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19772944)

  • 1. Interleukin 17 is not required for autoimmune-mediated pathologic damage during chronic graft-versus-host disease.
    Chen X; Das R; Komorowski R; van Snick J; Uyttenhove C; Drobyski WR
    Biol Blood Marrow Transplant; 2010 Jan; 16(1):123-8. PubMed ID: 19772944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.
    Chen X; Vodanovic-Jankovic S; Johnson B; Keller M; Komorowski R; Drobyski WR
    Blood; 2007 Nov; 110(10):3804-13. PubMed ID: 17693581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease.
    Anderson BE; McNiff JM; Matte C; Athanasiadis I; Shlomchik WD; Shlomchik MJ
    Blood; 2004 Sep; 104(5):1565-73. PubMed ID: 15150080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct roles for donor- and host-derived antigen-presenting cells and costimulatory molecules in murine chronic graft-versus-host disease: requirements depend on target organ.
    Anderson BE; McNiff JM; Jain D; Blazar BR; Shlomchik WD; Shlomchik MJ
    Blood; 2005 Mar; 105(5):2227-34. PubMed ID: 15522961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification and characteristics of IL-22-producing T cells in acute graft-versus-host disease following allogeneic bone marrow transplantation.
    Zhao K; Zhao D; Huang D; Song X; Chen C; Pan B; Wu Q; Cao J; Yao Y; Zeng L; Xu K
    Immunobiology; 2013 Dec; 218(12):1505-13. PubMed ID: 23816304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergent autoimmunity in graft-versus-host disease.
    Tivol E; Komorowski R; Drobyski WR
    Blood; 2005 Jun; 105(12):4885-91. PubMed ID: 15746077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
    Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
    Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Donor CD4+ T and B cells in transplants induce chronic graft-versus-host disease with autoimmune manifestations.
    Zhang C; Todorov I; Zhang Z; Liu Y; Kandeel F; Forman S; Strober S; Zeng D
    Blood; 2006 Apr; 107(7):2993-3001. PubMed ID: 16352808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.
    Kim W; Kim J; Jung D; Kim H; Choi HJ; Cho HR; Kwon B
    Biol Blood Marrow Transplant; 2009 Mar; 15(3):306-14. PubMed ID: 19203721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Chronic Graft-versus-Host Disease in MHC-Matched Mouse Strains: Genetics, Graft Composition, and Tissue Targets.
    Müller AMS; Min D; Wernig G; Levy RB; Perez VL; Herretes S; Florek M; Burnett C; Weinberg K; Shizuru JA
    Biol Blood Marrow Transplant; 2019 Dec; 25(12):2338-2349. PubMed ID: 31415899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
    Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
    Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction.
    Schmitt M; Taniguchi M; Yoshida T; Miyahara Y; Gu X; Mukai K; Yagita H; Dohner H; Shiku H
    Int J Oncol; 2002 Oct; 21(4):795-801. PubMed ID: 12239618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrafollicular CD4
    Deng R; Hurtz C; Song Q; Yue C; Xiao G; Yu H; Wu X; Muschen M; Forman S; Martin PJ; Zeng D
    Nat Commun; 2017 Oct; 8(1):978. PubMed ID: 29042531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alleviation of chronic GVHD in mice by oral immuneregulation toward recipient pretransplant splenocytes does not jeopardize the graft versus leukemia effect.
    Ilan Y; Margalit M; Ohana M; Gotsman I; Rabbani E; Engelhardt D; Nagler A
    Hum Immunol; 2005 Mar; 66(3):231-40. PubMed ID: 15784461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-17C/IL-17 Receptor E Signaling in CD4
    Krohn S; Nies JF; Kapffer S; Schmidt T; Riedel JH; Kaffke A; Peters A; Borchers A; Steinmetz OM; Krebs CF; Turner JE; Brix SR; Paust HJ; Stahl RAK; Panzer U
    J Am Soc Nephrol; 2018 Apr; 29(4):1210-1222. PubMed ID: 29483158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue-resident PSGL1loCD4+ T cells promote B cell differentiation and chronic graft-versus-host disease-associated autoimmunity.
    Kong X; Zeng D; Wu X; Wang B; Yang S; Song Q; Zhu Y; Salas M; Qin H; Nasri U; Haas KM; Riggs AD; Nakamura R; Martin PJ; Huang A; Zeng D
    J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 32931481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.
    Das R; Chen X; Komorowski R; Hessner MJ; Drobyski WR
    Blood; 2009 Mar; 113(10):2352-62. PubMed ID: 19059877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-2 inhibits graft-versus-host disease-promoting activity of CD4+ cells while preserving CD4- and CD8-mediated graft-versus-leukemia effects.
    Sykes M; Harty MW; Szot GL; Pearson DA
    Blood; 1994 May; 83(9):2560-9. PubMed ID: 7909457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic regulation of effector IFN-γ-producing and IL-17-producing T cell subsets in the development of acute graft-versus-host disease.
    Zhao K; Ruan S; Yin L; Zhao D; Chen C; Pan B; Zeng L; Li Z; Xu K
    Mol Med Rep; 2016 Feb; 13(2):1395-403. PubMed ID: 26647759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-22 promoted CD3+ T cell infiltration by IL-22R induced STAT3 phosphorylation in murine acute graft versus host disease target organs after allogeneic bone marrow transplantation.
    Zhao K; Ruan S; Tian Y; Zhao D; Chen C; Pan B; Yan Z; Yin L; Zhu S; Xu K
    Int Immunopharmacol; 2016 Oct; 39():383-388. PubMed ID: 27551984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.